glp 1 agonist dpp 4 inhibitor How does sitagliptin work? DPP-4 inhibitors and GLP-1 mimetics Insight into Structure Activity Relationship
Description
Wadden TA, Webb VL, Moran CH, Bailer BA
The newest kid on the block The ATTAIN-2 trial was conducted across 10 countries and involved more than 1,600 people who were obese or overweight with type 2 diabetes
Science ., doi: 10.1126/science.ado5019.
The oral GLP-1 component is becoming commercially important as it allows combining the promise of efficacy generated by injectable GLP-1 drugs with the convenience of the oral route of administration
Food does the gentle, real version for almost nothing
It increases satiety while reducing hunger, meaning you feel full faster with smaller meals
